基本信息
views: 23
Career Trajectory
Bio
Dr. Bruner’s leadership, especially in the National Cancer Institute (NCI) sponsored National Clinical Trials Network (NCTN) transcends disciplines and has led to improved health and quality of life and decreased cost outcomes for those treated for cancer. Recognition of her work led to her appointment by President Obama to one of only two National Institutes of Health Presidential appointed committees, the National Cancer Institute (NCI), National Cancer Advisory Board, on which she still serves. In 2021, in commemoration of the 50th Anniversary of the National Cancer Act, she was recognized among only 14 scientists in the area of cancer prevention and control as Champion and Changemakers. She is a member of the National Academy of Medicine and has co-authored several reports including most recently, Radioactive Sources: Applications and Alternative Technologies, and has served as a consultant to the Division of Human Health at the International Atomic Energy Agency, Vienna, Austria. Dr. Bruner has won numerous awards for research and mentorship. She has mentored nursing, psychology, epidemiology and medical junior faculty as well as pre- and post-doctoral students/fellows and has served as primary mentor for both nurses and physicians on 9 career development awards.
Dr. Bruner has worked for almost three decades with the NCTN and is the first and only nurse to ever lead a national clinical trials cooperative group, first as the Principal Investigator (PI) of the Radiation Therapy Oncology Group (RTOG) Community Clinical Oncology Program (CCOP), and currently as multi-PI of the NRG Oncology group National Community Oncology Research Program (NCORP). NRG Oncology was formed by the historic merger of The National Surgical Adjuvant Breast and Prostate (NSABP), the RTOG, and the Gynecologic Oncology Group (GOG) in March 2014. NRG is a consortium of over 1900 institutions and involving over 3,000 physicians, nurses, physicists, and statisticians, in the U.S. and Canada. The NCORP focuses on symptom amelioration, quality of life and comparative effectiveness trials in community settings, where most cancer care is delivered. Dr. Bruner’s pioneering leadership in the NCTN led to a paradigm shift from a historically medically dominated focus on survival and toxicity, to a patient-centered bio-behavioral focus that includes patient reported outcomes (PROs) and has changed clinical practice. She also currently serves on NRG Oncology’s Executive Committee.
Dr. Bruner has worked for almost three decades with the NCTN and is the first and only nurse to ever lead a national clinical trials cooperative group, first as the Principal Investigator (PI) of the Radiation Therapy Oncology Group (RTOG) Community Clinical Oncology Program (CCOP), and currently as multi-PI of the NRG Oncology group National Community Oncology Research Program (NCORP). NRG Oncology was formed by the historic merger of The National Surgical Adjuvant Breast and Prostate (NSABP), the RTOG, and the Gynecologic Oncology Group (GOG) in March 2014. NRG is a consortium of over 1900 institutions and involving over 3,000 physicians, nurses, physicists, and statisticians, in the U.S. and Canada. The NCORP focuses on symptom amelioration, quality of life and comparative effectiveness trials in community settings, where most cancer care is delivered. Dr. Bruner’s pioneering leadership in the NCTN led to a paradigm shift from a historically medically dominated focus on survival and toxicity, to a patient-centered bio-behavioral focus that includes patient reported outcomes (PROs) and has changed clinical practice. She also currently serves on NRG Oncology’s Executive Committee.
Research Interests
Papers共 471 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of clinical oncology : official journal of the American Society of Clinical Oncologyno. 20 (2024): 2377-2381
Journal of clinical oncology : official journal of the American Society of Clinical Oncologyno. 20 (2024): 2456-2487
Journal of Translational Medicineno. 1 (2024): 1-18
James J. Dignam,Paul A Romitti, Sue S. Yom,Felix Y Feng, Jeffrey D. Bradley,Minesh P. Mehta,Deborah Watkins Bruner,Jennifer Wenzel,Eleftherios P. Mamounas,Thomas J. George,Theodore S. Hong,Carol Aghajanian,
Journal of Clinical Oncologyno. 16_suppl (2024)
Cancer Researchno. 6_Supplement (2024): 6300-6300
Journal of Clinical and Translational Scienceno. s1 (2024): 129-130
Quality of Life Researchpp.1-12, (2024)
Molecular psychiatry (2024)
Cancer Researchno. 6_Supplement (2024): 6379-6379
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): e18918-e18918
Load More
Author Statistics
#Papers: 482
#Citation: 16453
H-Index: 59
G-Index: 120
Sociability: 8
Diversity: 1
Activity: 4
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn